January 2023VivaVision and Everads Collaborate to Develop Durable and Effective Therapies for Retinal Diseases. Delivery of VivaVision's...
newsJuly 2022Everads Therapy announced today that Israel’s Innovation Authority (IIA) has awarded a grant to help fund the company’s research and...
